
Discover Harvard’s groundbreaking research on psychedelics.
Latest Research
-
Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design
S. D. Muthumaraswamy et al., including Eduardo Schenberg; Therapeutic Advances in Psychopharmacology
Co-authored by Petrie-Flom Center’s Psychedelic Use, Law, and Spiritual Experience (PULSE) Affiliated Researcher, Eduardo Schenberg. Psychedelic-assisted therapy (PAT) has typically been evaluated using conventional randomised controlled trials (RCTs), which assess treatment efficacy under highly controlled conditions. However, PAT constitutes a complex intervention, integrating pharmacological, psychotherapeutic and contextual elements that interact dynamically with patient experiences and healthcare settings.
-
“Ketamine Integration Chaplaincy: A Novel Spiritual Care Approach to Psychedelic Integration”
Jeffrey Breau, Paul Gillis-Smith, & Tara Deonauth; Anthropology of Consciousness
Ketamine and esketamine are regularly prescribed in the United States as pharmaceutical interventions for treatment-resistant depression. Although ketamine’s mode of action is distinct from classic psychedelics, patients frequently report similar alterations in consciousness, including experiences described as spiritual or religious. This article provides an overview of the Ketamine Integration Chaplaincy (KIC) program developed at a university teaching hospital, which provides spiritual care and integration support to patients receiving ketamine. This pilot program offers virtual, one-on-one support to patients and may be one of the first instances of a major hospital providing ketamine integration modeled on spiritual care. The program supported 50 patients and trained four student chaplains from 2022 to 2025. This article reviews the current literature on ketamine-assisted psychotherapy and discusses hospital chaplaincy’s longstanding relationship to altered states of consciousness. It articulates why contemporary hospital chaplaincy techniques are well-suited for patients receiving ketamine and other psychedelic treatments. The article then presents the KIC program, including its genesis, training structure, and approach to integration. The article details the theory and practice of six chaplaincy competencies deployed by the KIC program: nondirective presence, facilitating meaning-making, spiritually supportive listening, altered states support, ritual design, and community care.
-
“Psychedelic-Assisted Therapy Training in the US: A Landscape Analysis”
Roman Palitsky, Caroline Peacock, Jeffrey Breau, Paul Gillis-Smith, & Gosia Sklodowska; Preprint
Commissioned by the CSWR and conducted by leading experts Roman Palitsky, MDiv, PhD (Emory Spiritual Health, Woodruff Health Sciences Center and Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine) and Caroline Peacock, LCSW, DMin (Emory Spiritual Health and Winship Cancer Center Institute), the report’s findings are based on 13 established and emerging psychedelic facilitation training programs and presents the first detailed systematic analysis of both growing strengths and notable gaps in spiritual, existential, religious, and theological (SERT) care training.
-
From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice
Eduardo Schenberg, Pharmacology Research & Perspectives
Petrie-Flom Center Psychedelic Use, Law, and Spiritual Experience (PULSE) Affiliated Researcher Eduardo Schenberg writes about how the recent review of a new drug application for MDMA-assisted therapy for post traumatic stress disorder by the United States’ Food and Drug Administration (FDA) highlighted epistemological and methodological challenges for evidence assessments.
-
“Beyond Counterculture: Towards a People’s History of Psychedelic Networks”
J. Christian Greer, CSWR, Psychedelic Intersections: 2024 Conference Anthology
J. Christian Greer articulates a history of psychedelic communities without relying upon the poorly understood label “counterculture.” The counterculture falsely categorizes psychedelic communities as monolithic and united in their opposition to mainstream society. To counter this, Greer argues that the term “psychedelicism” better captures the complexity and cultural centrality of psychedelic-using communities.
-
“With Best Intention: Psychedelic Intention-Setting Rituals as Rites of Sacralization”
Jeffrey Breau, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Jeffrey Breau explores the role that intention-setting rituals play in psychedelic settings, drawing from ethnographic research at the annual Burning Man gathering in Black Rock City, Nevada. He argues that intention-setting is best understood as a “rite of sacralization,” a practice meant to symbolically mark a psychedelic trip as special and sacred.
-
“A Post-Cringe Theory of Psychedelic Spirituality in the Rave Scene”
Michelle Lhooq, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Michelle Lhooq draws from her experience as a rave organizer and journalist to deploy the concept of “cringe” as an analytical tool to identify outdated tropes in the dance music scene. In an essay that is equally practical and philosophical, Lhooq argues that cringe is a corrective to the co-optation of ecstasy and transcendence by capitalist interests and shares her attempts to reinvigorate the psychedelic rave space in light of this.
-
“Soul Quest Ayahuasca Church of Mother Earth v. The DEA: Religious Sincerity and Situational Adjustments in the Process of Defining a Church and a Plant”
Tarryl Janik, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Tarryl Janik draws on his ethnography of Soul Quest, a Florida-based entheogenic church, to document how the organization attempted to navigate myriad legal and regulatory requirements. In complying with the government’s demands, Janik argues that Soul Quest undermined its religious sincerity case, ultimately leading to the church’s dissolution.
-
“The Legal Definition of Religion in the Context of Modern Religious Exercise with Psychedelics: Protection, Double Standards, and Potential Expansion under RFRA”
Allison Hoots, CSWR, Psychedelic Intersections: 2024 Conference Anthology
As an attorney for psychedelic organizations, Allison Hoots provides a detailed review of the case law that informs the structure and existence of modern psychedelic churches in the U.S. She concludes by arguing that the law fails to account for modern religious practice and aligns too closely with Protestant conceptions of true religiosity. As psychedelics remain federally illegal, religious communities in the US that incorporate such drugs into their practice must try to operate outside the awareness of the government or maneuver through the DEA’s religious exemption process.
-
“Manufacturing the Entheogenic Underground”
Brad Stoddard, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Brad Stoddard shows how the underground is, in fact, created and maintained by government policy. As a result, psychedelic churches operating illegally must, at the same time, conform their beliefs and practices to the will of the state.
-
“Spiritual Promiscuity, Psychedelic Interdependence, and The First World Congress of Sorcery”
Julián Sánchez González, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Julián Sánchez González examines the proximity of cultural production to cultural appropriation at the 1975 “First World Congress of Sorcery” (Primero Congreso Mundial de Brujería) in Bogotá, Colombia. Sánchez González analyzes the intermixing of politics, race, and cosmologies that took place there in terms of “spiritual promiscuity,” highlighting such cultural convergences as simultaneously deviant, generative, and sacred.
-
“The Interconnection of Psychedelic Spirituality, Social Justice, and BIPOC Therapist Engagement in Psychedelic-Assisted Therapy”
Candace Oglesby and Yvan Beaussant, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Candace Oglesby and Yvan Beaussant presents a qualitative study of the experiences of BIPOC therapists who are familiar with or have practiced psychedelic-assisted therapy. They enumerate the barriers BIPOC therapists face to their involvement in psychedelic-assisted therapy, and they gesture to the central role that social justice must play in therapy for BIPOC therapists, psychedelic or otherwise.
-
“Relationality in Psychedelic Facilitation Training Programs: The UC Berkeley Case”
Moana Meadow, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Moana Meadow’s essay demonstrates how the Berkeley Psychedelic Facilitation Certificate Program trains psychedelic facilitators through a relational and culturally sensitive approach.
-
“Facilitating the Sacred: The Role of Chaplains in Psychedelic Law and Policy”
Victoria Litman, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Victoria Litman, the Petrie-Flom Center Fellow in Psychedelic Law and Spirituality, argues that the current regulatory model’s exclusion of chaplains as psychedelic facilitators undermines the efficacy of psychedelic care. Her essay details the role that chaplains can and should play in psychedelic treatments and makes a forceful case for updating the policy surrounding both clinical and non-clinical psychedelic use to allow for trained chaplains to serve as facilitators.
-
“Psychedelic Projections: Hidden Narratives Shaping Psychedelic Medicine”
Franklin King, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Franklin King draws from his experience as a Mass General Hospital psychiatrist to explore the hidden narratives often underlying conversations about psychedelics. King argues that revealing these narratives is necessary to understand disagreements about psychedelic treatment and the ways that psychedelics become metonyms for larger philosophical and ideological agendas. This, in turn, will allow psychedelic researchers and advocates to free themselves from the flawed assumption that psychedelics alone will change the world.
-
“Toward a Psychedelic Theodicy: Psychedelic Biomedicine and the Concept of ‘Risk’”
Sharday Mosurinjohn, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Sharday Mosurinjohn interrogates and critiques a biomedical approach to “bad trips.” From this critique, Mosurinjohn proposes a theodicy grounded in animist philosophy as an alternative approach to difficult psychedelic experiences and, specifically, difficult entity encounters.
-
“Psychedelic Atmospherics”
Alex Gearin, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Alex Gearin provides an ethnographic account of “atmospherics,” the affective and perceptual elements of a setting, in Indigenous-led ayahuasca ceremonies in Peru and “neoshamanic” ceremonies in Australia. Gearin argues that “atmospherics” accounts for a far more active role of the environment in which one takes a psychedelic than what has become known simply as “setting,” as in “set and setting.”
-
“The Soma Question: Interrogating the History of Psychedelics with Sanskrit Mantras”
Finnian Moore-Gerety, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Finnian Moore Gerety traces the enduring interest in the authentic botanical identity of soma in the Vedic texts of the Hindu tradition. Moore Gerety argues that speculation on soma’s identity tracks with the drug fashions of the era in which thinkers speculated about soma’s botanical identity. He proposes a shift in focus away from certainty about soma’s botanical identity and towards the ritual and scripture pertaining to soma.
-
“God’s Pharmacy: On the Use of Entheogens in Jewish Mystical Traditions”
Anna Sierka, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Anna Sierka analyzes medieval Kabbalistic texts that illuminate the role of a potentially psychedelic plant—the “marking nut”— in Jewish mysticism. Using the marking nut as a primary example, Sierka argues that these texts can be divided into an exoteric tradition and an esoteric tradition. Texts in the exoteric tradition share the identity of the marking nut and related sacred plants in order to highlight their capacities for healing. Conversely, texts in the esoteric tradition hide the identity and role of these plant assistants to direct the reader away from any specific plant and toward the sacred knowledge obtained vis-à-vis these plants.
-
“From Messiah to Mushroom: A Brief History of John Marco Allegro’s The Sacred Mushroom and the Cross”
Geoffrey Smith, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Geoffrey Smith tracks the research and correspondence of the Dead Sea Scrolls scholar, John Marco Allegro, that led to his provocative conclusion that the New Testament gospel accounts are encoded texts disguising the truth that Jesus Christ and his apostles were not historical persons, but in fact psychoactive mushrooms. Smith concludes that Allegro’s mushroom hypothesis was informed by many trends in twentieth-century mycological study, alongside a desire to discredit Christianity from its inception.
-
“Religion of the Garden: An Interview with Luis Eduardo Luna”
Luis Eduardo Luna and Jeffrey Breau, CSWR, Psychedelic Intersections: 2024 Conference Anthology
Drawing from Luis Eduardo Luna’s keynote address at the 2024 “Psychedelic Intersections” conference, this interview essay explores Luna’s research on ayahuasca since the 1970s, his study of Indigenous cosmology and healing in South America, and his own spiritual development alongside these sacred plants.
-
“Introduction: Crossroads of Psychedelic Studies”
Jeffrey Breau and Paul Gillis-Smith, CSWR, Psychedelic Intersections: 2024 Conference Anthology
This essay provides an introduction for the CSWR’s new publication, the Psychedelic Intersections Conference Anthology. Co-editors Jeffrey Breau and Paul Gillis-Smith set the ground for the the volume, approaching psychedelics intersectionally and with interdisciplinarity. They introduce the themes of the volumes essays: psychedelics and spirituality’s intersection with ancient traditions, indigenous traditions, race, medicine, and the underground.
-
Psychedelic Intersections: 2024 Conference Anthology
Jeffrey Breau and Paul Gillis-Smith, CSWR, Psychedelic Intersections: 2024 Conference Anthology
The Psychedelic Intersections: 2024 Conference Anthology presents interdisciplinary research from scholars and practitioners working at the crossroads of psychedelics, religion, medicine, race, Indigeneity, law, and the underground, history, anthropology, and beyond. Edited by Jeffrey Breau and Paul Gillis-Smith, the Anthology expands on research presented at the 2024 “Psychedelic Intersections: Cross-cultural Manifestations of the Sacred” conference.
-
Fragile Gains, Persistent Setbacks: The Muddled Arc of American Drug-Law Reform
Ifetayo Harvey, The Yale Law Journal Forum
Petrie-Flom Center Psychedelic Use, Law, and Spiritual Experience (PULSE) Affiliated Researcher Ifetayo Harvey analyzes the legal, social, and political dimensions of drug decriminalization in the context of current debates.
-
Separation of Drug Scheduling Powers
Mason Marks, Yale Law Journal Forum
Petrie-Flom Center Senior Fellow Mason Marks writes how drug scheduling places substances believed to be harmful and addictive under strict federal control. In 1970, Congress enacted the Controlled Substances Act (CSA), which split drug scheduling authority between executive departments to leverage their specialized expertise. Today, the CSA grants the Department of Health and Human Services (HHS) authority over scientific aspects of drug scheduling and the Drug Enforcement Administration (DEA) jurisdiction over nonscientific, law-enforcement-related matters. However, since 1970, the separation of scheduling powers has collapsed, and law enforcement officials have assumed powers reserved for public health experts. Bureaucratic drift, where policies diverge from what lawmakers attempted to achieve, has produced redundant responsibilities and unscientific scheduling outcomes that contradict the CSA text, purpose, and legislative history.
-
Psychedelic Medicine Exceptionalism
I. Glenn Cohen and Mason Marks, The American Journal of Bioethics
Research on psychedelic medicines is experiencing a revival. Some clinicians, scientists, and ethicists believe that psychedelics are so different from other treatments that they warrant special consideration in how they are researched, regulated, commercialized, and administered. Others argue that psychedelic medicines show clinical potential, but they should be treated like other medical interventions. In other words, identical standards should apply. This article analyzes whether psychedelic medicines warrant special consideration from a regulatory and ethical perspective.
-
Focused Bodywork as Facilitated Communication: Cautionary Perspectives on Touch in Psychedelic Therapy
Neşe Devenot, The American Journal of Bioethics
Project on Psychedelic Law and Regulation (POPLAR) affiliated researcher at the Petrie-Flom Center highlights ethical concerns about the practice of “focused bodywork” that was utilized in MDMA-assisted therapy clinical trials.
-
Psychedelics, Psychosocial Support, and Psychotherapy: Why It Matters for the Law, Ethics, and Business of Medical Psychedelic Use
I. Glenn Cohen, Fordham Law Review
This Essay, Part of a Symposium on Drug Law for the 21st Century, proceeds as follow. Part I briefly describes how vociferous this debate has become among advocates for the medical use of psychedelics. Part II discusses why this choice matters, legally and ethically. This includes a discussion of the potential FDA approval process for psychedelics, implications for cost and access (including insurance), what it might mean for professionalization and licensure, and the future of supported adult use frameworks we have seen in states like Oregon.
-
Time to Abolish the DEA: Evaluating the Agency’s Failures and Calling for Community Investments
Ifetayo Harvey, Fordham Law Review
This Essay calls for a reimagining of how the United States approaches drug policy, starting with the abolition of the DEA. In making the case for abolition, this Essay will proceed in three parts. First, Part I will provide a brief history of the DEA and its mandate as prescribed by the U.S. government. Part II will provide a snapshot of the DEA’s approach to drug use and drug economies. Part III will explain why the DEA’s approach has historically been counterproductive and will highlight challenges the agency has faced in the twentieth century in addressing new and emerging issues in communities. This Essay concludes by urging readers to reimagine what American society could be if community care and access to resources took precedence over criminalization and enforcement as embodied by the DEA.
-
Intersections with Indigeneity in Psychedelic Buddhism
Colin Simonds, CSWR Psychedelic Intersections: 2024 Conference Anthology
This paper critically analyzes two approaches to Psychedelic Buddhism by Buddhist teachers Mike Crowley and Spring Washam and explores how these teachers think through, talk about, and engage with the Indigenous communities from which their practices originate.
-
Psychedelic therapies: healing for the wrong reasons?
Eduardo Schenberg, Christine Hauskeller, Claudia Gertraud Schwarz, and Franklin King IV, Nature Mental Health
When critically examining the assertion that biomedical treatments work for the ‘right’ reasons compared with alternative approaches, philosopher of science Isabelle Stengers1 coined the phrase ‘healing for the wrong reasons’. Here, we discuss the cognitive dissonances and regulatory misalignments apparent in the vote against MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) by the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee and the subsequent rejection of this new treatment by the FDA, and ways to realign this decision within a broader socio-cognitive context to ensure psychedelic therapies can benefit patients.
-
State Drug Laws
Mason Marks, Fordham Law Review
This Essay provides a typology of state drug laws comprising thirteen categories, including decriminalization, recriminalization, adult use, supported adult use, medical use, supported medical use, religious use, social consumption, safe consumption, clinical research, policy analysis, trigger laws, and food and agricultural laws. Several states have enacted hybrid legislation that blends features from different categories. A higher-level categorization can also be imposed onto the typology, dividing the categories into three broader groups, including laws regarding independent drug use, supervised drug use, and drug policy or procedure.
-
Xochipilli: Psychedelic Plants, Song, and Ritual in Aztec Religion
Osiris González Romero, CSWR Theosis
Xochipilli, a deity linked to songs, flowers, the rising sun, joy, games, and fertility, holds profound significance in Aztec religion. Historical sources characterize this deity as revered by nobles, elite principals, and guilds of artists, revered in both masculine and feminine forms. Yet Xochipilli is an understudied deity. This essay offers an overview of his features, including rituals consecrated in his honor.
-
Psychedelic Therapy Scrutinized by FDA Advisory Committee?
Mason Marks, JAMA Network
-
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
Amy L. McGuire, I. Glenn Cohen, Dominic Sisti, Mason Marks, et. al., JAMA Network
As government agencies around the globe contemplate approval of the first psychedelic medicines, many questions remain about their ethical integration into mainstream medical practice. From June 9 to 12, 2023, 27 individuals representing the perspectives of clinicians, researchers, Indigenous groups, industry, philanthropy, veterans, retreat facilitators, training programs, and bioethicists convened at the Banbury Center at Cold Spring Harbor Laboratory. This consensus statement reports 20 points of consensus across 5 ethical issues (reparations and reciprocity, equity, and respect; informed consent; professional boundaries and physical touch; personal experience; and gatekeeping), with corresponding relevant actors who will be responsible for implementation.
-
Branching Regulatory Paths and Dead Ends in Psychedelics
I. Glenn Cohen, The Regulatory Review
The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.
-
Essentials of Informed Consent to Psychedelic Medicine
Mason Marks, Rebecca W. Brendel, Carmel Shachar, I. Glenn Cohen, JAMA Psychiatry
Analysis of the challenges of designing and implementing psychedelic informed consent practices revealed 7 essential components, including the possibility of short- and long-term perceptual disturbances, potential personality changes and altered metaphysical beliefs, the limited role of reassuring physical touch, the potential for patient abuse or coercion, the role and risks of data collection, relevant practitioner disclosures, and interactive patient education and comprehension assessment. Because publicly available informed consent documents for psychedelic clinical trials often overlook or underemphasize these essential elements, sample language and procedures to fill the gap are proposed.
-
The Project on Psychedelics Law and Regulation (POPLAR)
Ongoing
Petrie-Flom Center
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Launched in summer 2021 with a generous grant from the Saisei Foundation, the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy.
-
State-Regulated Psychedelics on a Collision Course With FDA
Mason Marks, JAMA
Interest in researching and commercializing psychedelic medicines is growing. Substances such as psilocybin and 3,4-methylenedioxymethamphetamine show potential for treating conditions including depression and posttraumatic stress disorder. The Food and Drug Administration (FDA) may soon approve psychedelics for these and other indications.
-
From Entheogens to Evangelicalism: Spiritual Practices Among Hispanic/Latin Americans
Fernando Espi Forcen, Psychiatric Annals
Hispanic, Latinx people practice spirituality in a wide array of forms. Whereas Catholicism has been the dominant religion for centuries, a re-birth of Native American, African spirituality has taken place over the last few decades. In parallel, the influence of the United States in the Latin world is reflected in the rapidly growing popularity of Evangelical Christianity. In order to better understand, study spiritual practices in Latin America, one must understand the historical vicissitudes that led to the formation of these religions, the context in which they became ingrained in these territories.
-
Psychometric brahman, psychedelic science: Walter Stace, transnational Vedanta, and the Mystical Experience Questionnaire
Jeffrey Breau and Paul Gillis-Smith, Interdisciplinary Science Reviews
The longstanding juncture between science and religion in psychedelic research is mediated most notably by the Mystical Experience Questionnaire (MEQ). The MEQ is a psychometric survey for assessing mystical experiences, and it relies on the work of philosopher Walter Stace for its typology and philosophy of mysticism. Yet there is an under-investigated influence from Vedantic Hinduism that contributed to Stace’s thinking. In an analysis of Stace’s hermeneutics of mysticism, this article demonstrates how Stace’s typology of mystical experience was created in dialogue with major figures in the field of modern, transnational Vedanta.
-
How Should the FDA Evaluate Psychedelic Medicine?
Mason Marks and I. Glenn Cohen, New England Journal of Medicine
Mounting clinical evidence could lead to the approval of new psychedelic medicines. The FDA’s draft guidance on psychedelics research includes several recommendations that may be contentious.
-
Race, ethnicity moderate the associations between lifetime psilocybin use, crime arrests
Grant Jones, Maha Al-Suwaidi, Franchesca Castro-Ramirez, Taylor C. McGuire, Patrick Mair, Matthew K. Nock; Frontiers in Psychiatry
This study investigates how race, ethnicity moderate the associations between lifetime psilocybin use, crime arrests. Using data from the National Survey on Drug Use, Health (2002–2020) with 734,061 adults, it finds that race, ethnicity significantly moderate the associations between psilocybin use, crime arrests. The study suggests that racial, ethnic identity impacts the relationship between psilocybin use, crime, highlighting the need for further research into the intersection of sociodemographic factors, psychedelic use, crime.
-
Psychedelics, Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care
Kabir Nigam, Kimberly A. Curseen, Yvan Beaussant, Clinics in Geriatric Medicine
This review article discusses the potential of psychedelics, related pharmacotherapies as integrative medicine for older adults in palliative care. It explores the use of these substances in addressing existential distress, serious illness, end-of-life care, highlighting the need for further research, consideration of psychedelic-assisted therapy (PAT) in this context.
-
Pressing regulatory challenges for psychedelic medicine
Amy L. McGuire, Holly Fernandez Lynch, Lewis A. Grossman,, I. Glenn Cohen; Science
This article discusses the regulatory challenges faced in the development of psychedelic medicine. It highlights the growing interest, investment in psychedelic drug development, the complexities of applying traditional clinical trial, premarket approval processes to these substances. The article emphasizes the need for regulatory creativity, collaboration to maximize the therapeutic potential of psychedelics, considering their use outside the medical establishment, the limited evidence on their clinical benefits.
-
Pharmacotherapy, Ketamine Assisted Psychotherapy for Treatment-Resistant Depression: A Patient With Lifelong Self-Doubt, Self-Criticism
Albert Yeung, Guy Sapirstein, Laura D. Crain, Margaret A. Cramer, Fernando Espi Forcen, Susan Sprich, Jonah N. Cohen; The Journal of Clinical Psychiatry
This article discusses a case of treatment-resistant depression (TRD) in a 61-year-old patient named John, who had a long history of depression, inadequate responses to various treatments, including medications, therapy. The article explores John’s symptoms, including self-doubt, existential angst, anxiety, and the challenges he faced in managing his depression.
Subscribe for Updates
Get the latest news about programming, research and opportunities from across Harvard University.
Harvard Study of Psychedelics in Society and Culture Mailing List
CSWR Newsletter | Petrie-Flom Center Newsletter | Mahindra Humanities Center Newsletter